LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)

J.D. Spicer, Shugeng Gao, Moïshe Liberman et al. · Annals of Oncology · 2023

Cited by 85 works. doi:10.1016/j.annonc.2023.10.052 Open-access PDF

Authors

References